Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibit... by Lu, Shun, Prof, Wu, Lin, Prof, Jian, Hong, MD, Chen, Ying, Prof, Wang, Qiming, MD, Fang, Jian, Prof, Wang, Ziping, MD, Hu, Yanping, Prof, Sun, Meili, MD, Han, Liang, MD, Miao, Liyun, Prof, Ding, Cuimin, MD, Cui, Jiuwei, Prof, Li, Baolan, Prof, Pan, Yueyin, Prof, Li, Xingya, MD, Ye, Feng, MD, Liu, Anwen, Prof, Wang, Ke, MD, Cang, Shundong, MD, Zhou, Hui, MD, Sun, Xing, MD, Ferry, David, MD, Lin, Yong, MD, Wang, Shuyan, MD, Zhang, Wen, MD, Zhang, Chengli, MD

Get full text

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final anal... by Zhou, Caicun, Prof, Wang, Ziping, Prof, Sun, Yuping, Prof, Cao, Lejie, Prof, Ma, Zhiyong, Prof, Wu, Rong, Prof, Yu, Yan, Prof, Yao, Wenxiu, Prof, Chang, Jianhua, Prof, Chen, Jianhua, Prof, Zhuang, Wu, BM, Cui, Jiuwei, Prof, Chen, Xueqin, Prof, Lu, You, Prof, Shen, Hong, MD, Wang, Jingru, PhD, Li, Peiqi, MD, Qin, Mengmeng, MMed, Lu, Dongmei, MSc, Yang, Jason, MD

Get full text

Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407 by Cheng, Ying, MD, Zhang, Li, MD, Hu, Jie, MD, PhD, FCCP, Wang, Donglin, MD, Hu, ChengPing, MD, Zhou, Jianying, MD, Wu, Lin, MD, Cao, Lejie, MD, Liu, Jiwei, MD, Zhang, Helong, MD, Sun, Hong, MD, Wang, Ziping, PhD, Gao, Hongjun, MD, Sun, Yuping, MD, Li, Ben, PhD, Hu, Xiaohan, PhD, MPH, Schwarzenberger, Paul, MD, Paz-Ares, Luis, MD, PhD

Get full text